Nearly 80% of cancer drugs approved by the FDA in recent years have clinical trial uncertainties, but journals and guidelines ...

Over the past 20 years, a class of cancer drugs called CD40 agonist antibodies have shown great promise—and induced great disappointment.

The findings challenge long-standing assumptions about therapy-related cancers. They also highlight how drug actions can substitute for genetic changes in tumor development. An international team of ...

Researchers have successfully used repurposed cancer drugs to target dormant breast cancer cells, aiding in the delay or prevention of recurrence, according to a study published Sept. 2 in Nature ...

In a new study, two cancer drugs showed signs of slowing or reversing symptoms of Alzheimer’s disease.

Scientists at UCSF and Gladstone Institutes have identified cancer drugs that promise to reverse the changes that occur in the brain during Alzheimer’s, potentially slowing or even reversing its ...

With few treatments available to treat Alzheimer’s disease, scientists have turned to cancer drugs as a potential means of walking back cognitive decline.